Sponsored AnnouncementNovember 6, 2026

Cognitive assessment software

VoxNeuro brings FDA-cleared cfNI cognitive assessment to practices with no equipment purchase

cfNI records EEG/ERP during a 20 to 30 minute, staff-run assessment and returns a structured report for clinician review. Hardware included; pay per assessment.

K253015FDA 510(k) clearance
20 to 30 minAssessment session
18 to 70Adult age range

CAMBRIDGE, Mass. VoxNeuro USA Inc. is offering its Cognitive Function Neuroimaging (cfNI) Software to neurology practices, TMS clinics, primary care practices and diagnostic imaging centers in the United States. The model requires no equipment purchase. Compatible EEG hardware is included, VoxNeuro trains the practice’s existing staff to collect the data, and the practice pays per assessment.

cfNI is FDA-cleared (510(k) K253015) prescription-use software for adults 18 to 70. It records EEG while a patient completes a set of cognitive tasks and measures the brain’s event-related potentials (ERPs) during each task. The software then produces a structured report that a qualified clinician reviews alongside the rest of the clinical picture.

A patient and staff member seated across a table with assessment equipment
A cfNI session: a patient and staff member seated across a table with the assessment equipment. Photo supplied by VoxNeuro.

What happens in a 20 to 30 minute session

A trained staff member runs the session while the patient completes five tasks. The tasks are a resting-state recording, an auditory oddball task, a go/no-go task, a visual memory task and a flanker task. The software analyzes the recordings and generates the report automatically.

Each task gets its own page in the report. ERP measurements are shown beside the patient’s behavioral performance on the same report, and scores are compared with age-matched reference data from healthy adults aged 18 to 70. Repeat assessments show score changes since the last visit, across up to four appointments.

Staff collect. Clinicians interpret.

The model separates data collection from report review. Operator training prepares the practice’s existing staff to run the assessment, and interpretation training prepares its physicians to read the report. Both are included. The report does not provide a diagnosis or clinical interpretation; it is intended to support the qualified healthcare professional who makes that call.

Where it fits

  • Neurology practices

    Behavioral performance and brain response captured together, with progress tracked across visits.
  • Primary care practices

    A staff-run assessment with a structured report for the clinician to review.
  • TMS clinics

    EEG/ERP measurements collected at baseline and repeated during the care pathway, alongside existing scales.
  • Diagnostic imaging centers

    A complementary EEG/ERP service for referring clinicians, with staff-led collection and a structured report.

Pricing model

Practices pay per assessment plus a one-time setup and training fee. Hardware is included, so there is no equipment purchase. Minimums and contract terms are discussed with the VoxNeuro team.

The research behind it

cfNI grew out of more than three decades of work in John Connolly’s laboratory at McMaster University. The lab measured cognitive function from the brain’s electrical activity, including in people who could not take a test at all. VoxNeuro was founded in 2017 by John Connolly, James Connolly and Kimberly Elliott to bring that research into clinical practice. The report has been in clinical use since 2022, and the software received FDA clearance in 2026.

Quality and compliance

VoxNeuro holds ISO 13485:2016 certification for its quality management system, certified by Intertek. cfNI is developed under IEC 62304 for software lifecycle and ISO 14971 for risk management, and VoxNeuro operates as a HIPAA-compliant service.

Practices evaluating the assessment can view a sample cfNI report, check their readiness and talk to the VoxNeuro team at voxneuro.com.

VoxNeuro USA Inc. develops software that gives qualified clinicians objective EEG/ERP measurements to review alongside their clinical assessments. VoxNeuro’s Cognitive Function Neuroimaging (cfNI) Software is FDA-cleared (510(k) K253015), prescription-use software indicated for adults 18 to 70 years of age. It does not provide a diagnosis or clinical interpretation; the outcome report is intended to support, not replace, interpretation by a qualified healthcare professional.

About this announcement

This is a paid placement supplied by or prepared for VoxNeuro USA Inc. Product descriptions, regulatory statements, dates and figures are attributable to VoxNeuro. Device Pulse has not tested cfNI. cfNI also appears in the Device Pulse ranking of EEG/ERP cognitive assessment systems, which discloses this relationship beside the ranking.

Illustrated portrait of Rome Thorndike

Rome Thorndike

Rome Thorndike is the CEO & Founder of Provyx, which provides GTM intelligence and data validation for healthcare companies, including EngagedMD and BTL Industries. His healthcare experience includes Microsoft accounts such as John Muir Health and commercial advisory work for Kaironexus.

Connect on LinkedIn